Brad Wyman

a TBG consultant and recognized expert with more than 20 years of experience in the strategy, deployment, and delivery of all aspects of clinical trials—including study design, protocol development, study documentation, CRO management, regulatory submissions, and working with statisticians and data management to deliver and interpret study results. His expertise includes the research and creation of novel, fit-for-purpose, imaging biomarkers and ensuring their correct deployment in trials for go/no-go decision making.